First-trimester TPOAb/TgAb autoimmunity phenotypes and pregnancy complications and neonatal outcomes: a single-center retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Objective To examine associations of first-trimester thyroid peroxidase antibody (TPOAb)/thyroglobulin antibody (TgAb) phenotypes with maternal and neonatal outcomes. Methods This single-center retrospective cohort included 728 pregnancies for maternal analyses and 715 clinically evaluable live-born mother–infant dyads for neonatal analyses. Non-live births and records with birth weight below 500 g or otherwise non-evaluable neonatal status were excluded from the neonatal analysis. Participants were classified into four first-trimester TPOAb/TgAb antibody phenotypes: double-negative (TPOAb−/TgAb−), TPOAb-positive-only (TPOAb+/TgAb−), TgAb-positive-only (TPOAb−/TgAb+), and double-positive (TPOAb+/TgAb+). Multivariable models were fitted with and without log-transformed TSH and FT4 adjustment; continuous antibody analyses and Benjamini–Hochberg false discovery rate (FDR) correction were also performed. Results Of 728 women, 588 (80.8%) were double-negative, 44 (6.0%) were TPOAb-positive-only, 36 (4.9%) were TgAb-positive-only, and 60 (8.2%) were double-positive. Crude phenotype differences were observed for gestational diabetes mellitus (GDM; P = 0.033), any recorded comorbidity ( P = 0.009), and mid/late-pregnancy thyroid dysfunction ( P < 0.001). In the fully adjusted model, the TgAb-positive-only phenotype showed a nominal association with GDM (OR 2.81, 95% CI 1.31–6.05; P = 0.008), which did not remain significant after FDR correction (q = 0.068). Continuous antibody analyses showed no GDM dose-response pattern. The double-positive phenotype remained associated with thyroid dysfunction after FDR correction (OR 12.27, 95% CI 2.57–58.52; P = 0.002; q = 0.042), whereas the TPOAb-positive-only association was nominal (OR 6.22, 95% CI 1.61–24.11; P = 0.008; q = 0.068). No stable adjusted associations were observed for the assessed neonatal outcomes. Conclusion The TgAb-positive-only GDM signal was hypothesis-generating and requires external validation before clinical use. The double-positive thyroid-dysfunction association requires cautious interpretation because only 19 events occurred and a severity gradient between antibody-positive phenotypes was not established. First-trimester antibody phenotype should be interpreted as a baseline contextual marker rather than a direct measure of later disease status or severity. Antibody phenotype alone should not guide diagnosis, treatment, or intensified surveillance.
Source: Frontiers in Medicine
Authors: Wei Liu(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing), Dan Zhou(Data curation, Formal analysis, Investigation, Methodology, Writing – original draft), Dazhi Fan(Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing), Xiaoling Guo(Conceptualization, Data curation, Formal analysis, Methodology, Supervision, Writing – original draft, Writing – review & editing)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: thyroid peroxidase antibodies, thyroglobulin antibodies, gestational diabetes mellitus, pregnancy complications, neonatal outcomes, neonatal hypothyroidism, neonatal hyperthyroidism, neonatal thyroid dysfunction, maternal thyroid dysfunction, maternal thyroid function, live birth, mother-infant dyads, dose-response relationship
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7237218532
